Skip to content
Omnikalc

HAS-BLED score calculator: bleeding risk on anticoagulation

Add up the nine HAS-BLED items to estimate the yearly risk of major bleeding in a person with atrial fibrillation taking an anticoagulant.

Updated on
Your inputs
Uncontrolled hypertension, systolic above 160 mmHg (H)
Abnormal kidney function: dialysis, transplant or creatinine ≥ 2.26 mg/dL (A)
Abnormal liver function: cirrhosis, or bilirubin > 2× and enzymes > 3× normal (A)
Prior stroke (S)
Prior major bleeding or bleeding tendency (B)
Labile INR, time in therapeutic range below 60% (L)
Age over 65 (E)
Antiplatelet drugs or NSAIDs (D)
Alcohol, 8 or more drinks a week (D)

Results

HAS-BLED score

2

Moderate bleeding risk
Major bleeds per 100 patient-years (original cohort)
1.88
Modifiable items checked (H, L, drugs, alcohol)
1

What HAS-BLED is for

People with atrial fibrillation often take an anticoagulant to prevent strokes. The trade-off is a higher risk of bleeding. HAS-BLED, published by Pisters and colleagues in 2010 from the Euro Heart Survey, estimates that bleeding risk with nine simple items, each worth one point.

The nine items

Letter Item Points
H Uncontrolled hypertension, systolic above 160 mmHg 1
A Abnormal kidney function: dialysis, transplant, creatinine ≥ 2.26 mg/dL 1
A Abnormal liver function: cirrhosis, or bilirubin > 2× and liver enzymes > 3× normal 1
S Prior stroke 1
B Prior major bleeding or a bleeding tendency such as anemia 1
L Labile INR, time in therapeutic range below 60% (warfarin users) 1
E Elderly, over 65 1
D Drugs: antiplatelets or NSAIDs 1
D Alcohol, 8 or more drinks a week 1

Worked example

A 72-year-old with blood pressure that stays above 160 mmHg and no other items:

  1. H: 1 point; E: 1 point.
  2. Total: 2 points, a moderate bleeding risk.
  3. In the original cohort, a score of 2 matched about 1.88 major bleeds per 100 patient-years.

Bleeding rates by score

Score Major bleeds per 100 patient-years
0 1.13
1 1.02
2 1.88
3 3.74
4 8.70
5 12.50

These figures come from a single cohort; rates in other populations differ, but the trend holds.

How the score is used

A score of 3 or more flags a high bleeding risk. Current guidelines do not use it as a reason to withhold anticoagulation, because the stroke risk usually outweighs the bleeding risk. Instead, the score points to factors that can be fixed: bringing blood pressure under control, stopping unneeded aspirin or NSAIDs, reducing alcohol and improving INR control or switching to a direct oral anticoagulant. The calculator counts these modifiable items separately.

HAS-BLED is used alongside CHA₂DS₂-VASc, which estimates stroke risk. The two scores share several items, such as age, hypertension and prior stroke, which shows how closely stroke and bleeding risks are linked.

This calculator is for general information and education. It is not medical advice and does not replace the judgment of a doctor, nurse or pharmacist who knows the full clinical picture.

Frequently asked questions

What does the HAS-BLED score measure?

HAS-BLED estimates the yearly risk of major bleeding in people with atrial fibrillation who take an anticoagulant. Each of nine items scores 1 point, for a total from 0 to 9.

What is a high HAS-BLED score?

A score of 3 or more marks a high bleeding risk. In the original cohort, the rate of major bleeding rose from about 1 per 100 patient-years at 0 or 1 point to 3.74 at 3 points and 8.70 at 4 points.

Should anticoagulation be stopped if HAS-BLED is high?

No, not on the score alone. Guidelines use a high score to flag patients who need closer follow-up and correction of modifiable factors such as uncontrolled blood pressure, NSAIDs, alcohol or an unstable INR.

How is HAS-BLED different from CHA₂DS₂-VASc?

CHA₂DS₂-VASc estimates the risk of stroke without treatment, which supports the decision to anticoagulate. HAS-BLED estimates the risk of bleeding on treatment. The two are used together.

Was this calculator helpful?

Thanks for your feedback!

Results are estimates provided for information purposes. They do not replace professional advice.